Vivimed Labs Ltd
VIVIMEDLAB (NSE)

10.00

83.33
Proj. ROE (%)
-
Proj. P/E (x)
-
Proj EV / EBITDA (x)
-
Proj. P/BV (x)
-
Proj. Revenue ( Cr.)
-

Stock View

-
Share on
The average score for Vivimed Labs Ltd stands at 2 against 1, three months back.

Vivimed Labs Limited is an India-based company, which is primarily engaged in the business of active pharmaceuticals ingredients, contract development and manufacturing operations (CDMO) finished dosage formulation, specialty chemicals and retail branded formulation manufacturing. It operates in two segments: Specialty Chemicals Business and Pharma Business. It serves various companies through the contract manufacturing (CMO) division, which offers a range of products, such as capsules and tablets, syrups and liquids, and nasal sprays and ointments. The active ingredients manufactured by the Company are used in home and personal care segments, such as hair, skin, oral care and anti-microbial preservatives. Its products include DICLOFENAC GEL BP, LULICONAZOLE CREAM, PERMETHRIN LOTION, and CLOTRIMAZOLE VAGINAL GEL. Its subsidiaries include Finoso Pharma Private Limited, Vivimed Specialty Chemicals Private Limited, Vivimed Holdings Limited, and Vivimed Labs USA INC.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
12.95
100 DMA ()
15.22
200 DMA ()
17.88
52 Weeks Range
7.60
27.45
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity